Publications by authors named "Syrine Saffar"
Article Synopsis
- Therapeutic drug monitoring (TDM) for anti-TNF-α treatments, like infliximab and adalimumab, is crucial for managing inflammatory diseases, and this study assessed the effectiveness of different serum measurement assays.
- Four immunoassays (Promonitor, i-Track10, ez-track1, and Lisa Tracker ELISA) were compared, showing varying levels of agreement, with Promonitor performing particularly well for infliximab and adalimumab measurements.
- Despite acceptable performance for monitoring the drugs, the study advises using the same assay consistently for each patient due to imperfect concordance between the methods, particularly for infliximab.
